PubRank

Irving L Kron

Author PubWeight™ 181.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2014 7.23
2 Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2013 6.21
3 Blood transfusion and infection after cardiac surgery. Ann Thorac Surg 2013 3.35
4 Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med 2015 3.11
5 Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg 2006 2.98
6 Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol 2004 2.62
7 Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg 2009 2.10
8 Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg 2012 2.09
9 Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 2002 1.91
10 Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2006 1.80
11 Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg 2012 1.73
12 Primary payer status affects mortality for major surgical operations. Ann Surg 2010 1.69
13 Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery? Ann Thorac Surg 2009 1.63
14 Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv 2013 1.53
15 Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg 2009 1.53
16 High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg 2010 1.52
17 Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg 2008 1.52
18 Sleep deprivation does not affect operative results in cardiac surgery. Ann Thorac Surg 2004 1.51
19 Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2004 1.50
20 Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol 2007 1.48
21 Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg 2010 1.47
22 Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg 2013 1.45
23 Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg 2006 1.44
24 Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg 2007 1.42
25 Replacement of the proximal aorta adds no further risk to aortic valve procedures. Ann Thorac Surg 2007 1.40
26 Caring for the residents: the view of two program directors. Ann Thorac Surg 2004 1.38
27 Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev 2004 1.37
28 Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 2011 1.35
29 CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2009 1.28
30 Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg 2005 1.22
31 Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg 2012 1.18
32 Endoscopic versus open saphenous vein harvest for femoral to below the knee arterial bypass using saphenous vein graft. J Vasc Surg 2006 1.18
33 Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2009 1.17
34 Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg 2011 1.17
35 Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg 2011 1.16
36 Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg 2011 1.14
37 The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann Thorac Surg 2009 1.13
38 NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol 2008 1.13
39 Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development. J Heart Lung Transplant 2010 1.12
40 Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004 1.11
41 Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg 2011 1.11
42 Mitral repair is superior to replacement when associated with coronary artery disease. Ann Surg 2004 1.11
43 Hospital procedure volume should not be used as a measure of surgical quality. Ann Surg 2012 1.09
44 Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg 2009 1.09
45 The effect of surgeon volume on mortality for off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2012 1.08
46 Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann Thorac Surg 2011 1.07
47 A simplified approach to degenerative disease: triangular resections of the mitral valve. Ann Thorac Surg 2007 1.07
48 Cardiac injury during resternotomy does not affect perioperative mortality. J Am Coll Surg 2008 1.07
49 Adenosine A₂A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg 2011 1.07
50 The impact of coronary artery endarterectomy on outcomes during coronary artery bypass grafting. J Card Surg 2011 1.07
51 Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002 1.06
52 Primary payer status is associated with mortality and resource utilization for coronary artery bypass grafting. Circulation 2012 1.05
53 Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation 2012 1.04
54 Elimination of fat microemboli during cardiopulmonary bypass. Ann Thorac Surg 2003 1.03
55 Acute sleep deprivation in the thoracic surgical resident does not affect operative outcomes. Ann Thorac Surg 2005 1.03
56 Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2010 1.01
57 Primary payer status affects outcomes for cardiac valve operations. J Am Coll Surg 2011 0.99
58 A change in perspective: results for ischemic mitral valve repair are similar to mitral valve repair for degenerative disease. Ann Thorac Surg 2007 0.98
59 A contemporary cost analysis of postoperative morbidity after coronary artery bypass grafting with and without concomitant aortic valve replacement to improve patient quality and cost-effective care. Ann Thorac Surg 2013 0.98
60 Recurrent cystic adventitial disease of the popliteal artery: successful treatment with percutaneous transluminal angioplasty. Vasc Endovascular Surg 2009 0.98
61 Surgical management of the patient with metastatic melanoma to the heart. J Card Surg 2013 0.97
62 Percutaneous transluminal angioplasty and stenting in the treatment of chronic mesenteric ischemia: results and longterm followup. J Am Coll Surg 2002 0.96
63 Reevaluating the need for left subclavian artery revascularization with thoracic endovascular aortic repair. Ann Thorac Surg 2007 0.96
64 Keratinocyte growth factor enhances post-pneumonectomy lung growth by alveolar proliferation. Circulation 2002 0.96
65 Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemia-reperfusion injury. Ann Thorac Surg 2007 0.95
66 Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg 2009 0.95
67 Concomitant tricuspid valve operations affect outcomes after mitral operations: a multiinstitutional, statewide analysis. Ann Thorac Surg 2012 0.94
68 Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model. J Thorac Cardiovasc Surg 2012 0.93
69 Albumin is a better predictor of outcomes than body mass index following coronary artery bypass grafting. Surgery 2011 0.93
70 Differential vascular growth in postpneumonectomy compensatory lung growth. J Thorac Cardiovasc Surg 2007 0.93
71 Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2010 0.92
72 Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg 2008 0.92
73 Safety and efficacy of the supraclavicular approach to thoracic outlet decompression. Ann Thorac Surg 2003 0.92
74 Anomalous origin of the right coronary artery: right internal thoracic artery to right coronary artery bypass is not the answer. J Thorac Cardiovasc Surg 2007 0.92
75 Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation. Respir Res 2009 0.92
76 Beneficial effects of inhaled nitric oxide in adult cardiac surgical patients. Ann Thorac Surg 2002 0.91
77 Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2010 0.91
78 Enhanced fibrinolysis protects against lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2009 0.91
79 Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg 2010 0.90
80 Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 2009 0.90
81 The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation. J Thorac Cardiovasc Surg 2004 0.89
82 Have thoracic endografting outcomes improved since US Food and Drug Administration approval? Ann Thorac Surg 2011 0.89
83 Mediastinal thymoma invading the superior vena cava and the right atrium. Acta Cardiol 2007 0.89
84 Short and long-term outcomes for bidirectional glenn procedure performed with and without cardiopulmonary bypass. Ann Thorac Surg 2012 0.89
85 Should all ischemic mitral regurgitation be repaired? When should we replace? Curr Opin Cardiol 2011 0.88
86 Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons. Ann Thorac Surg 2002 0.88
87 Outcomes of reoperative aortic valve replacement after previous sternotomy. J Thorac Cardiovasc Surg 2009 0.88
88 Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circ Heart Fail 2013 0.87
89 Examination of sex as an independent risk factor for adverse events after carotid endarterectomy. J Vasc Surg 2005 0.87
90 Preoperative beta-blocker use should not be a quality metric for coronary artery bypass grafting. Ann Thorac Surg 2013 0.87
91 Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation. Am J Physiol Lung Cell Mol Physiol 2011 0.87
92 Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J Vasc Surg 2002 0.87
93 Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States. Ann Thorac Surg 2011 0.87
94 Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma. J Surg Res 2004 0.86
95 Rapamycin blocks fibrocyte migration and attenuates bronchiolitis obliterans in a murine model. Ann Thorac Surg 2013 0.86
96 Prevention of the second stage of epithelial loss is a potential novel treatment for bronchiolitis obliterans. J Thorac Cardiovasc Surg 2012 0.86
97 Previous percutaneous coronary intervention increases morbidity after coronary artery bypass grafting. Surgery 2012 0.86
98 Sex and gender in thoracic aortic aneurysms and dissection. Semin Thorac Cardiovasc Surg 2011 0.86
99 Elective thoracic aortic aneurysm surgery: better outcomes from high-volume centers. J Am Coll Surg 2010 0.86
100 Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 2010 0.85
101 Stem cell therapy for ischemic heart disease: where are we? Curr Opin Organ Transplant 2009 0.85
102 Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation. J Thorac Cardiovasc Surg 2008 0.85
103 Adenosine A2A analogue improves neurologic outcome after spinal cord trauma in the rabbit. J Trauma 2002 0.85
104 Surgical mentorship. J Thorac Cardiovasc Surg 2011 0.85
105 Hyperoxic ventilation exacerbates lung reperfusion injury. J Thorac Cardiovasc Surg 2005 0.85
106 Small prosthesis size in aortic valve replacement does not affect mortality. Ann Thorac Surg 2011 0.85
107 Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI. Am J Physiol Heart Circ Physiol 2008 0.84
108 Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2013 0.83
109 Pulmonary inflammation after lung transplantation. Surgery 2009 0.83
110 Outcomes and cost of cardiac surgery in octogenarians is related to type of operation: a multiinstitutional analysis. Ann Thorac Surg 2011 0.83
111 Pulmonary artery and conduit reintervention rates after norwood using a right ventricle to pulmonary artery conduit. Ann Thorac Surg 2011 0.82
112 The beating heart approach is not necessary for the Dor procedure. Ann Thorac Surg 2003 0.82
113 Use of a nonpledgeted suture technique is safe and efficient for aortic valve replacement. J Thorac Cardiovasc Surg 2010 0.82
114 Geographic distance between donor and recipient does not influence outcomes after lung transplantation. Ann Thorac Surg 2011 0.81
115 Development of a novel murine model of aortic aneurysms using peri-adventitial elastase. Surgery 2012 0.81
116 Early repair of complete atrioventricular septal defect is safe and effective. Ann Thorac Surg 2006 0.81
117 Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. J Thorac Cardiovasc Surg 2002 0.81
118 Elective hypothermic circulatory arrest to address aortic pathology is safe for the elderly. J Card Surg 2009 0.81
119 Coronary risk stratification in patients with end-stage lung disease. J Heart Lung Transplant 2002 0.81
120 Adenosine A3 receptor activation attenuates lung ischemia-reperfusion injury. Ann Thorac Surg 2013 0.81
121 Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death. Transplantation 2015 0.81
122 Preoperative shock determines outcome for acute type A aortic dissection. Ann Thorac Surg 2003 0.81
123 Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling. Am J Respir Cell Mol Biol 2011 0.81
124 Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism. J Vasc Surg 2006 0.80
125 Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation. Ann Thorac Surg 2010 0.80
126 A comparison of adenosine A2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits. J Neurosurg Spine 2006 0.80
127 Complete versus partial atrioventricular canal: equal risks of repair in the modern era. Ann Surg 2002 0.80
128 Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury. Ann Thorac Surg 2005 0.80
129 Contemporary outcomes for surgical mitral valve repair: a benchmark for evaluating emerging mitral valve technology. J Thorac Cardiovasc Surg 2012 0.80
130 Pyrrolidine dithiocarbamate reduces lung reperfusion injury. J Surg Res 2003 0.80
131 Transesophageal echocardiographic guidance for surgical repair of aortic insufficiency in congenital heart disease. J Am Soc Echocardiogr 2007 0.79
132 The health workforce: a position statement. Ann Surg 2007 0.79
133 Controlled perfusion decreases reperfusion injury after high-flow reperfusion. J Heart Lung Transplant 2002 0.79
134 New strategies for surgical management of ischemic cardiomyopathy. Expert Rev Cardiovasc Ther 2008 0.79
135 Early adenosine receptor activation ameliorates spinal cord reperfusion injury. J Cardiovasc Med (Hagerstown) 2008 0.79
136 Timing of stroke after cardiopulmonary bypass determines mortality. Ann Thorac Surg 2008 0.79
137 Contrasting natures of lung growth after transplantation and lobectomy. J Thorac Cardiovasc Surg 2002 0.79
138 Adenosine A2A activation attenuates nontransplantation lung reperfusion injury. J Surg Res 2007 0.78
139 Subvalvular techniques to optimize surgical repair of ischemic mitral regurgitation. Curr Opin Cardiol 2014 0.78
140 Transverse arch hypoplasia may predispose patients to aneurysm formation after patch repair of aortic coarctation. Ann Thorac Surg 2003 0.78
141 Coarctation of a right aortic arch. J Card Surg 2006 0.78
142 Time of year does not influence mortality for vascular operations at academic centers. J Vasc Surg 2011 0.78
143 Surgery for severe ischemic mitral regurgitation. N Engl J Med 2014 0.78
144 Research incentive program for clinical surgical faculty associated with increases in research productivity. J Thorac Cardiovasc Surg 2012 0.78
145 Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice. Basic Res Cardiol 2015 0.77
146 Predictors of operative mortality in cardiac surgical patients with prolonged intensive care unit duration. J Am Coll Surg 2013 0.77
147 Lung transplantation in patients 60 years and older: results, complications, and outcomes. Ann Thorac Surg 2006 0.77
148 Does urgent or emergent status influence choice in mitral valve operations? An analysis of outcomes from the Virginia Cardiac Surgery Quality Initiative. Ann Thorac Surg 2010 0.77
149 Does preoperative ejection fraction predict operative mortality with left ventricular restoration? Ann Thorac Surg 2006 0.77
150 Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms. FASEB J 2013 0.76
151 Reinitiation of compensatory lung growth after subsequent lung resection. J Thorac Cardiovasc Surg 2007 0.76
152 Thoracic aortic endografting is the treatment of choice for elderly patients with thoracic aortic disease. Ann Surg 2006 0.76
153 Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. J Thorac Cardiovasc Surg 2011 0.76
154 Influence of hemodialysis on clinical outcomes after lung transplantation. J Surg Res 2013 0.76
155 Endothelial nitric oxide synthase is essential for postpneumonectomy compensatory vasodilation. Ann Thorac Surg 2006 0.76
156 An unusual case of cardiac dysfunction after left ventricular reconstruction. J Cardiothorac Surg 2006 0.76
157 Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. J Thorac Cardiovasc Surg 2008 0.76
158 Nonagenarians undergoing cardiac surgery. J Card Surg 2014 0.75
159 The case to unify cardiac and vascular surgery. J Thorac Cardiovasc Surg 2008 0.75
160 Ventricular reconstruction results in improved left ventricular function and amelioration of mitral insufficiency. Ann Surg 2002 0.75
161 Resident research forums stimulate novel research within general surgical training programs. J Surg Educ 2009 0.75
162 Ventricular assist devices and increased blood product utilization for cardiac transplantation. J Card Surg 2014 0.75
163 Academic season does not influence cardiac surgical outcomes at US Academic Medical Centers. J Am Coll Surg 2011 0.75
164 Preoperative computed tomography is associated with lower risk of perioperative stroke in reoperative cardiac surgery. Interact Cardiovasc Thorac Surg 2011 0.75
165 Fate of the unligated vertical vein after surgical correction with total anomalous pulmonary venous connection in early infancy. J Thorac Cardiovasc Surg 2002 0.75
166 Characterization of novel synthesized small molecular compounds against non-small cell lung cancer. Ann Thorac Surg 2011 0.75
167 Predicting operative mortality after surgery for ischemic cardiomyopathy. Ann Thorac Surg 2007 0.75
168 Advances in cardiac and aortic surgery. Preface. Surg Clin North Am 2009 0.75
169 Modified aortoplasty for discrete congenital supravalvular aortic stenosis. J Thorac Cardiovasc Surg 2012 0.75
170 A protocol-driven approach to cardiac reoperation reduces mortality and cardiac injury at the time of resternotomy. Ann Thorac Surg 2013 0.75
171 Preliminary experience with an endobronchial blocker designed for young children. J Cardiothorac Vasc Anesth 2003 0.75
172 Modern concepts in heart transplantation. J Long Term Eff Med Implants 2003 0.75
173 Coronary abscess in an adolescent with a structurally normal heart. J Am Coll Cardiol 2011 0.75
174 Hyperinflation during lung preservation and increased reperfusion injury. J Surg Res 2005 0.75
175 How many lives did you save today? Ann Thorac Surg 2006 0.75
176 Inferior vena cava filter migration to the heart. Ann Thorac Surg 2008 0.75
177 Complications of coarctation repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2002 0.75
178 Valve-sparing aortic root reconstruction. Surg Clin North Am 2009 0.75
179 Attenuation of lung reperfusion injury by modified ventilation and reperfusion techniques. J Heart Lung Transplant 2006 0.75
180 Cardiothoracic surgery and the National Institutes of Health and National Heart, Lung, and Blood Institute. J Thorac Cardiovasc Surg 2011 0.75